ライフサイエンスコーパス: advanced-stage

1 e were 218 patients in the protocol (98 with advanced stage).

2 in asymptomatic until the disease reaches an advanced stage.

3 ith increased resection correlated with more advanced stage.

4 prognosis, particularly when diagnosed at an advanced stage.

5 omas characterized by only poor prognosis in advanced stage.

6 ase progressing from the intermediate to the advanced stage.

7 pharyngeal cancers are often diagnosed at an advanced stage.

8 est survival when treatment was initiated at advanced stage.

9 sensitive progression detector from early to advanced stages.

10 crospore formation but had no effect on more advanced stages.

11 rcinoma (HCC), which is usually diagnosed at advanced stages.

12 early stages from the referable intermediate/advanced stages.

13 ung-onset colon cancer was initially seen at advanced stages (61.8% had stage III or IV).

14 mor diameter, para-aortic nodal involvement, advanced stage, ADC90 and ADC95, nADC75, nADC90, and nAD

15 lable for up to 11,239 cases (including 1654 advanced stage and 1741 aggressive) and 18,541 controls

16 hat the MnSOD/AMPK pathway is most active in advanced stage and aggressive breast cancer subtypes.

17 rs (NSCLCs), which are often diagnosed at an advanced stage and associated with poor prognosis.

18 re its appearance in older male individuals, advanced stage and bilateral manifestation at the time o

19 ocarcinoma (CC) is typically diagnosed at an advanced stage and is refractory to surgical interventio

20 Advanced stage and poor treatment completion contributed

21 Overexpression of COX-2 correlates with advanced stage and worse outcomes in non-small-cell lung

22 cinoma (CCRCC) is an incurable malignancy in advanced stages and needs newer therapeutic targets.

23 or B3GALT5 was significantly associated with advanced stages and poor outcome.

24 indicate that LGR5 expression was reduced in advanced stages and positively correlated with markers o

25 he elevated TIP-1 levels are associated with advanced staging and poor prognosis in glioma patients.

26 phorus was associated with increased risk of advanced-stage and high-grade disease 0-8 y after exposu

27 ake was associated with an increased risk of advanced-stage and high-grade disease 12-16 y after expo

28 as been associated with an increased risk of advanced-stage and high-grade prostate cancer.

29 In a patient-derived xenograft model of advanced-stage and platinum-resistant ovarian cancer, an

30 xpress high levels of HSP70, particularly at advanced stages, and that phospho-FAK (PTK2) and BRAF ar

31 8 years or older) with previously untreated, advanced stage (Ann Arbor stage III or IV) follicular ly

32 Data on patients with HCC in NCL in advanced stages are scarce.

33 avorable risk, early stage unfavorable risk, advanced stage [AS] III/IV) and progression-free surviva

34 fic survival, partially attributed to a more advanced stage at diagnosis.

35 after pigmented melanoma because of its more advanced stage at diagnosis.

36 otic than pigmented melanoma because of more advanced stage at diagnosis.

37 th early-stage favorable than unfavorable or advanced stage at first diagnosis (15-year cumulative in

38 In a prospective study in patients with advanced-stage B-cell lymphoma, we investigated the prog

39 However, prostate cancer cells in advanced stages become resistant to inhibitory effects o

40 anti-interleukin-1alpha antibody therapy for advanced stage cancer is warranted.

41 is, and therapeutic monitoring from early to advanced stage cancer patients and to examine underlying

42 r extrahepatic cancer are considered to have advanced-stage cancer and could benefit from treatment w

43 Patients with advanced-stage cancer are receiving increasingly aggress

44 opulation of immature myeloid cells found in advanced-stage cancer patients and mouse tumor models.

45 sion of CD38(+) MDSCs in peripheral blood of advanced-stage cancer patients and validated targeting C

46 disorder has been estimated to be 30% of the advanced-stage cancer patients.

47 clinical results in a significant number of advanced-stage cancer patients.

48 (14.6% vs 0% [GOG trials were restricted to advanced-stage cancer]); and nonserous carcinomas (29.9%

49 wever, most previous studies have focused on advanced stage cancers, and few have evaluated ctDNA det

50 al colorectal adenocarcinomas, including 255 advanced-stage cancers, and 147 deaths from interval col

51 ecursor to HGSC and identifiable in 50% of advanced stage cases.

52 g in abnormal splice variants (AR-SV)-driven advanced stage castration-resistant disease.

53 By multivariate analysis, advanced stage, central nervous system involvement, leuk

54 Differences in attachment rate at this advanced stage correlate with local plasmonic field enha

55 d with worse OS for patients with early- and advanced stage CRC (P < 0.001).

56 with follicular lymphoma; P = .047) and with advanced stage disease (15 of 18 patients).

57 re for patients on treatments and those with advanced stage disease.

58 osis, and providing functional assessment in advanced stage disease.

59 t targeting this pathway may be effective in advanced stage disease.

60 , 31; 4-6 months, 31; and 7-9 months, 43) or advanced-stage disease (cases per 1000 8-30 days, 8; 2 m

61 Risk of any colorectal cancer and advanced-stage disease (defined as stage III and IV canc

62 ches are used for refractory early-stage and advanced-stage disease (IIB-IV) and include bexarotene,

63 1.05-2.08]; 49 cases per 1000 patients) and advanced-stage disease (OR, 1.97 [95% CI, 1.14-3.42]; 19

64 1.89-2.68]; 76 cases per 1000 patients) and advanced-stage disease (OR, 3.22 [95% CI, 2.44-4.25]; 31

65 her likelihood of solid subtype ( P < .001), advanced-stage disease at diagnosis ( P = .02), higher r

66 sociation with risk of colorectal cancer and advanced-stage disease at diagnosis.

67 a higher risk of colorectal cancer and more advanced-stage disease at the time of diagnosis.

68 es of any colorectal cancer and 601 cases of advanced-stage disease diagnosed.

69 9; and the HD15 trial enrolled patients with advanced-stage disease from Jan 28, 2003, to April 18, 2

70 Advanced-stage disease is common with uncharacteristic l

71 Patients with advanced-stage disease made up 53%.

72 Curative therapy for cancer patients with advanced-stage disease remains elusive.

73 biologic agents available, the treatment of advanced-stage disease still represents an unmet medical

74 The interval rate of advanced-stage disease was highest (>0.4 case per 1000 e

75 orld Health Organization classification with advanced-stage disease were identified and paired 1:2 wi

76 Greater reductions in advanced-stage disease yielded a greater screening effec

77 re deprived area, nonwhite ethnicity, having advanced-stage disease, having undergone radiotherapy, a

78 the success of future targeted therapies in advanced-stage disease.

79 %), the median age was 32 years, and 68% had advanced-stage disease.

80 omplete, particularly for patients with more advanced-stage disease.

81 n the development of both primary cancer and advanced-stage disease.

82 l such drugs are now routinely used to treat advanced-stage disease.

83 evelopment, and at distant sites, leading to advanced stage diseases.

84 This protective effect was strongest against advanced-stage EAC, and increased with statin dose.

85 association was strongest for patients with advanced-stage EAC: in a stratified analysis, comparison

86 curring genetic alterations in patients with advanced-stage EGFR-mutant lung cancer.

87 o-occurring oncogenic events present in most advanced-stage EGFR-mutant lung cancers.

88 ncluded those with histologically confirmed, advanced-stage, EGFR-mutant NSCLC.

89 y downregulated in poorly differentiated and advanced-stage endometrial carcinoma compared with level

90 and chemotherapy that induces regression of advanced stage EOC and significantly improves survival.-

91 d in an orthotopic, syngeneic mouse model of advanced stage EOC.

92 ntiangiogenic and chemotherapy treatments on advanced stage EOC.

93 in a large national population of women with advanced-stage EOC.

94 improves survival in a preclinical model of advanced stage epithelial ovarian cancer.

95 (PCS) vs neoadjuvant chemotherapy (NACT) for advanced-stage epithelial ovarian cancer (EOC).

96 ed with NACT in otherwise healthy women with advanced-stage epithelial ovarian cancer aged 70 years o

97 Advanced-stage epithelial ovarian cancers are amongst th

98 0)Y-IT is an effective initial treatment for advanced-stage FL in patients with higher tumor burden r

99 firms the favorable outcome of patients with advanced-stage FL treated with immunochemotherapy.

100 Advanced stage follicular lymphoma (FL) is incurable by

101 Eligible patients had symptomatic, advanced stage follicular lymphoma and were previously u

102 tenance as initial therapy for patients with advanced-stage follicular lymphoma (FL).

103 might represent a new therapeutic option for advanced-stage follicular lymphoma.

104 isone (CVP) in patients with newly diagnosed advanced-stage follicular lymphoma.

105 18)F-FDG avidity in the index malignancy, an advanced stage for that malignancy, and a clinician deci

106 serve as a safe and effective treatment for advanced-stage HCC patients with tumor PVT.

107 ses of chronic HCV infection and outcomes of advanced-stage HCV infection.

108 , early-stage unfavourable (HD14 trial), and advanced-stage (HD15 trial) Hodgkin's lymphoma.

109 d effectiveness of therapy for patients with advanced stage head and neck squamous cell carcinoma (HN

110 e report survival outcomes for patients with advanced-stage hepatocellular carcinoma (HCC) with porta

111 his difference was largely explained by more advanced stage, higher grade tumors, and a greater propo

112 eighty newly diagnosed early unfavorable and advanced-stage HL patients, all scanned at baseline and

113 imilar EFS and OS in patients with high-risk advanced-stage HL.

114 rapy can guide consolidating radiotherapy in advanced-stage Hodgkin lymphoma (HL).

115 Patients with advanced-stage Hodgkin lymphoma for whom treatment was a

116 anuary 2001 and December 2009, patients with advanced-stage Hodgkin lymphoma who had responded comple

117 y during first-line therapy in patients with advanced-stage Hodgkin lymphoma, in terms of providing a

118 astine, and bleomycin; CEC) in patients with advanced-stage Hodgkin lymphoma.

119 ge favourable, early-stage unfavourable, and advanced-stage Hodgkin's lymphoma from the HD13, HD14, a

120 .05-1.22), whereas no increase was found for advanced stages (HR = 0.98, 95% CI, 0.92-1.05).

121 N proto-oncogene is amplified in a number of advanced-stage human tumors, such as neuroblastomas.

122 25 Gy) for early stage (IA, IB, and IIA) and advanced stage (IIB-IV) with bulky disease.

123 ed on limited (stages I and II, nonbulky) or advanced (stage III or IV) disease, with stage II bulky

124 ized as localized (stages I and II), locally advanced (stages III and IVB), or metastatic (stage IVC)

125 r-naive patients with EGFR mutation-positive advanced (stage IIIb-IV) lung adenocarcinomas who were g

126 enus Thermus is more abundant in tissue from advanced stage (IIIB, IV) patients, while Legionella is

127 Horizontal branch stars belong to an advanced stage in the evolution of the oldest stellar ga

128 TP53 and CDKN2A alterations appeared at more advanced stages in aggressive tumors.

129 Prostate cancer at advanced stages including metastatic and castration-resi

130 f TF has in clinical studies correlated with advanced stage, increased microvessel density, metastasi

131 e plus rituximab in patients with untreated, advanced stage indolent non-Hodgkin lymphoma.

132 confidence interval [CI], 0.39 to 0.69), for advanced-stage interval cancer, 0.43 (95% CI, 0.29 to 0.

133 Small cell lung cancer (SCLC) at advanced stage is considered an incurable disease.

134 skin cancer; its prognosis, particularly in advanced stages, is disappointing largely due to the res

135 Advanced stage (IV) (P = 0.026), an SUVmax of less than

136 borious and suffer decreased sensitivity for advanced-stage lesions.

137 e good diagnostic and prognostic utility for advanced stage liver disease, and have been adapted into

138 ties are needed for a risk-free treatment of advanced stage liver diseases, including HCC.

139 Patients with advanced-stage, low-tumour-burden follicular lymphoma ha

140 tment option for patients with asymptomatic, advanced-stage, low-tumour-burden follicular lymphoma.

141 I2 gene) and SOX9, which are associated with advanced stage lung cancers and are implicated in the re

142 One patient with advanced-stage lung adenocarcinoma, who was treated with

143 146 family members of Medicare patients with advanced-stage lung or colorectal cancer in the Cancer C

144 ents and Methods We treated 22 patients with advanced-stage lymphoma in a clinical trial of CAR-19 T

145 y low-dose chemotherapy induced remission of advanced-stage lymphoma, and high serum IL-15 levels wer

146 early stages and gAD supplementation during advanced stages may potentially reduce the cerebral isch

147 ity populations have disproportionately more advanced stage melanoma and worse survival.

148 individuals presented with thick (>4 mm) or advanced-stage melanoma at diagnosis.

149 shown therapeutic benefit, in both early and advanced stage metastatic disease, especially when used

150 (225)Ac-PSMA-617 alpha-radiation therapy in advanced-stage, metastatic castration-resistant prostate

151 includes the largest cohort of patients with advanced-stage MF/SS and identifies markers with indepen

152 pecialist centers on patients diagnosed with advanced-stage MF/SS from 2007.

153 Advanced-stage mycosis fungoides (MF; stage IIB to IV) a

154 CAI2 expression was significantly higher in advanced-stage neuroblastoma, independently of MYCN ampl

155 ptimal therapy and outcome for patients with advanced-stage nodular lymphocyte-predominant Hodgkin ly

156 we analyzed longitudinal blood samples from advanced stage non-small cell lung cancer (NSCLC) patien

157 -3'-(18)F-fluorothymidine ((18)F-FLT) PET in advanced-stage non-small cell lung carcinoma (NSCLC) pat

158 when added to platinum-based chemotherapy in advanced-stage non-squamous NSCLC.

159 for elderly patients with a new diagnosis of advanced-stage NSCLC and were treated with antineoplasti

160 sion Considerable shifts in the treatment of advanced-stage NSCLC occurred along with modest gains in

161 in patients with early-stage NSCLC and with advanced-stage NSCLC treated with chemotherapy.

162 o inform value-based treatment decisions for advanced-stage NSCLC.

163 c function, without structural injury, to an advanced stage of biventricular dysfunction (H), differe

164 factor at all disease stages, including the advanced stage of castrate-resistant prostate cancer (CR

165 Despite the advanced stage of diamond thin-film technology, with app

166 Gastric cancer is usually diagnosed in an advanced stage of disease and treatment options are spar

167 d with pancreatic cancer clearly reflect the advanced stage of disease at diagnosis for most patients

168 cer; delays in diagnosis that result in more advanced stage of disease at presentation; inadequate re

169 of moderate to severe cataracts (P < .0001), advanced stage of glaucoma (P < .0001), and a diagnosis

170 anisms underlie reduced MEE at the early and advanced stage of hypertrophic cardiomyopathy.

171 evels (PKCdelta(+/+)hRBP) developed the most advanced stage of insulin resistance.

172 n of Dmp1 and Dspp, respectively, during the advanced stage of odontoblast differentiation.

173 lped to elucidate the general picture of the advanced stage of plant cell specialization and to revea

174 those that hold promise or are already at an advanced stage of testing (OsPSTOL1, AVP1, PHO1 and OsPH

175 f incurable disease status, knowledge of the advanced stage of the disease, and expectation to live m

176 Uruguay is at an advanced stage of the epidemiologic transition; like oth

177 ad centrifugally to tonsils and spleen at an advanced stage of the incubation period, thus explaining

178 nic drugs, but geographic atrophy (GA) is an advanced stage of the more prevalent "dry" form of AMD f

179 taben SUVRs appears to be negligible even in advanced stages of AD with a higher cerebellar Abeta loa

180 ls of complement, only uEVs of patients with advanced stages of ADPKD had increased levels of villin-

181 exaenoic acid (DHA) and the intermediate and advanced stages of age-related macular degeneration (AMD

182 ium of human eyes, particularly in eyes with advanced stages of age-related macular degeneration.

183 ith early (n = 9), intermediate (n = 5), and advanced stages of AMD (geographic atrophy, n = 5; neova

184 While reactive microgliosis is a hallmark of advanced stages of amyotrophic lateral sclerosis (ALS),

185 therefore seems to be a common event in the advanced stages of apoptosis, when caspase-3 is active.

186 rgets to decrease the inflammatory burden in advanced stages of atherosclerosis.

187 on and myeloid cell recruitment at early and advanced stages of atherosclerosis.

188 This isoform is highly expressed in advanced stages of breast and cervical tumors.

189 el of GIT1 was significantly associated with advanced stages of breast cancer, as well as with lymph

190 In advanced stages of cancers, TGF-beta promotes tumor prog

191 cluding diabetes mellitus, hypertension, and advanced stages of chronic kidney disease at baseline.

192 endent prognostic indicator in patients with advanced stages of chronic lymphocytic leukaemia (CLL).

193 roved for therapeutic intervention or are in advanced stages of clinical development.

194 (MM), with several monoclonal antibodies in advanced stages of clinical development.

195 s, TGF-beta1 and IL-10, is a hallmark of the advanced stages of cutaneous T cell lymphoma (CTCL), whe

196 tripeptide-based HCV protease inhibitors in advanced stages of development for which cross-resistanc

197 e microscopes, (ii) scalability by analyzing advanced stages of development with up to 20,000 cells p

198 plant-based vaccines, some of them being in advanced stages of development.

199 the SOCS1 peptidomimetic at either early or advanced stages of diabetes ameliorated STAT activity an

200 and volume are significantly reduced in more advanced stages of diabetic retinopathy.

201 ven percent of eyes in decade 1 demonstrated advanced stages of disease (stage 3B or worse) compared

202 have been documented in patients treated at advanced stages of disease, including improvement in liv

203 lgus macaques when treatment is initiated at advanced stages of disease, including up to 8 d after ch

204 ed predominantly in combinations and in very advanced stages of disease.

205 nd factor, in human and rat liver tissue, at advanced stages of fibrosis caused by either biliary or

206 At advanced stages of FSGS, fawn-hooded hypertensive rat ki

207 s, three of which became pregnant and are in advanced stages of gestation.

208 mineralocorticoid receptor blockers in less advanced stages of heart, renal, and vascular disease.

209 g on episodic memory and motor function with advanced stages of HIV infection suggests that these two

210 Behavioral fever manifested only at advanced stages of infection.

211 anhydroglucitol (1,5-AG) are associated with advanced stages of kidney disease independent of kidney

212 By contrast, in advanced stages of Kras-driven murine PDAC, loss of p53

213 Advanced stages of liver cirrhosis lead to a dramaticall

214 8 patients with persistent HCV infection and advanced stages of liver fibrosis or cirrhosis and 20 co

215 trend of basal cell density decline in more advanced stages of LSCD.

216 (NP-targeting) siRNA in nonhuman primates at advanced stages of MARV or RAVV disease to mimic cases i

217 w being used more commonly for patients with advanced stages of melanoma, can exacerbate autoimmune d

218 Advanced stages of neuroblastoma, the most common extrac

219 rse biodegradation and photooxidation during advanced stages of oil weathering.

220 ges (with a high peroxide value) and oils in advanced stages of oxidation, with secondary oxidation c

221 ocyte levels were significantly increased in advanced stages of PAOD, while classical and non-classic

222 In advanced stages of Parkinson's disease, serotonergic ter

223 patients in 3 groups of mild, moderate, and advanced stages of PD were recruited for 18F-DTBZ PET sc

224 ere seen in poorly differentiated and highly advanced stages of prostate cancer and correlated with p

225 cid at 22, 40, and 70 degrees C at early and advanced stages of reaction.

226 The association with advanced stages of ROP is a concern and needs to be furt

227 sults show that the retinal transcriptome at advanced stages of RP is very similar to that of other r

228 VLScT may occur at advanced stages of scaffold resorption.

229 as to determine the association between more advanced stages of temporomandibular joint (TMJ) intra-a

230 ood, and treatment options for patients with advanced stages of the disease are limited.

231 the shift from a Th1 to a Th17 imbalance at advanced stages of the disease suggests the necessity to

232 ) is important for progression to the deadly advanced stages of the disease, it is poorly understood

233 r are subtle and become apparent only during advanced stages of the disease.

234 hermore, no effective therapy exists for the advanced stages of the disease.

235 n increase in proinflammatory MC function in advanced stages of the disease.

236 l synapse in mouse models, even in adults at advanced stages of the disease.

237 ell lines and human tumor samples, mainly in advanced stages of the disease.

238 ts with lymphoma, the PNSs often develops at advanced stages of the disease.

239 could thus contribute to axonal dystrophy in advanced stages of the disease.

240 is usually lost or significantly reduced in advanced stages of the disease.

241 Markers of the early and advanced stages of the Maillard reaction were also follo

242 ate well with reactive lysine content if the advanced stages of the reaction had not been reached.

243 ogs, rcd1 and xlpra2, at clinically relevant advanced stages of the two diseases.

244 a acts as a tumor suppressor, whereas in the advanced stages of these cancers, increased TGF-beta exp

245 Advanced stages of this inherited rare amyloidosis, pres

246 ; thus, novel approaches to the treatment of advanced stages of this non-Hodgkin lymphoma are clearly

247 ized-system raises a promising treatment for advanced stages of this rare amyloidotic disease, and al

248 The closer epidemiologists get to advanced stages of translation, the more likely they are

249 alformations of myelin ultrastructure in the advanced stages of Wallerian degradation is known, its s

250 e some form of palliation because of locally advanced stage or distant metastasis, where it cannot be

251 rall risk of prostate cancer or with risk of advanced-stage or aggressive disease.

252 g the presence of B symptoms, bulky disease, advanced stage, or extranodal disease), relapse.

253 nti-IL6 and gefitinib to treat patients with advanced stage ovarian cancer.

254 e surgery (PCS) by identifying patients with advanced-stage ovarian cancer in whom > 1 cm of residual

255 Patients with suspected advanced-stage ovarian cancer who qualified for PCS were

256 ognosis and quality-of-life of patients with advanced-stage ovarian cancer.

257 tile laparotomies in patients with suspected advanced-stage ovarian cancer.

258 P = .01; HR, 6.75; 95% CI: 1.44, 120.5), and advanced stage (P = .03; HR, 3.16; 95% CI: 1.94, 4.56) w

259 r lesions (P = .02), and a trend toward less advanced stage (P = .06).

260 e rate and thyroid cancer mortality rate for advanced-stage papillary thyroid cancer.

261 The management of advanced stage Parkinson's disease can be complex.

262 We compared advanced stage patients with HCC (American Joint Committ

263 diagnosis (and were otherwise untreated) to advanced stage patients with HCC who received no therapy

264 ssociated with melanoma-specific survival in advanced-stage patients (rs10515789, multivariate P=0.02

265 ancer drug therapies almost always occurs in advanced-stage patients even following a significant res

266 identified subsets of BCLC intermediate- and advanced-stage patients for more aggressive treatments t

267 nitial therapeutic response, the majority of advanced-stage patients relapse and succumb to chemoresi

268 For advanced-stage patients who were event free at 2 years,

269 For advanced-stage patients, a treatment activity of 100 kBq

270 prognostic index, may be useful to stratify advanced-stage patients.

271 as strong potential to significantly benefit advanced-stage prostate cancer patients.

272 Advanced-stage prostate cancer usually metastasizes to b

273 no elevated risk for overall, high-grade or advanced-stage prostate cancer, or death due to prostate

274 -617 radioligand therapy (RLT) is applied in advanced-stage prostate cancer.

275 -year cumulative risk of cancer after LT for advanced-stage PSC was 18.7%, with posttransplant lympho

276 or-initiating cells (TIC) is vital to combat advanced-stage recurrent cancers.

277 Late and advanced stage relapse are rarely seen.

278 (OAC) has emerged as a primary treatment for advanced-stage retinoblastoma.

279 , this region appears crescent-shaped, while advanced stages show a ring-like pattern.

280 argeted therapy are rare in individuals with advanced-stage solid cancers.

281 rol of disease, or a cure, for patients with advanced-stage solid cancers.

282 ssion was significantly correlated with more advanced stages (stage III and IV) (p < 0.05).

283 ings of ADC value of early (stage I, II) and advanced stages (stage III, IV) of thymic epithelial tum

284 of the spindle-like tumours with metastasis, advanced stage, suboptimal debulking and poor prognosis.

285 = 15) and inactive older men and women with advanced-stage, symptomatic knee osteoarthritis (OA) (n

286 S are treated with cART alone; patients with advanced-stage (T1) KS receive cART plus liposomal anthr

287 al cancer (EC) are generally diagnosed at an advanced stage, translating into a poor survival rate.

288 multi-center integrated genomic analysis of advanced stage tumors with and without STIC lesions and

289 opean cohort, with a focus on high-grade and advanced-stage tumors, and death due to prostate cancer.

290 5OHD concentrations were lower in women with advanced-stage tumors, and the lowest in premenopausal w

291 ve increased survival times of patients with advanced-stage tumors, such as melanoma or lung cancer.

292 od tumors and their propensity to present at advanced stages, updated long-term data are needed.

293 eral ocular involvement at presentation, and advanced stage were significantly correlated with shorte

294 patients are diagnosed at an intermediate to advanced stage when surgery is not suitable.

295 ith the majority of patients diagnosed at an advanced stage where curative therapeutic options are la

296 osed with epithelial ovarian cancer (EOC) at advanced stage, where therapies have limited effectivene

297 cell response was observed in patients at an advanced stage, whereas the coexpression of markers that

298 y and mortality owing to diagnosis at a more advanced stage, which suggests that nonwhite organ trans

299 Early-stage FEVR may progress to more advanced stages, which can result in vision loss.

300 lymphoma that is generally incurable at more advanced stages with systemic involvement.